Localised non-Hodgkin's lymphoma: The Sheffield Lymphoma Group experience (1970-1995)

International Journal of Oncology

Volumn 13, Issue 6, 1998, Pages 1313-1318

  Dobson, L S ^a   Hancock, H ^a   Bright, N ^a   Robinson, M H ^a   Hancock, B W ^a  

^a WESTON PARK HOSPITAL   (United Kingdom)

Author keywords

Extranodal; Localised nodal; Non Hodgkin's lymphoma

Indexed keywords

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031770586     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.6.1313     Document Type: Article

References (14)

1. National Cancer Institute sponsored study of classification of non-Hodgkin's Iymphomas: Summary and description of a working formulation for clinical usage. The non-Hodgkin's lymphoma pathologic classification project. Cancer 49: 2112-2135, 1982.
2. Modan B, Shani M, Goldman B and Modan M: Nodal and extranodal malignant lymphoma in Istrael: an epidemiological study. Br J Haematol 16: 53-59, 1969.
3. Freeman C, Berg JW and Cutler SJ: Occurrence and prognosis of extranodal lymphomas. Cancer 29: 252-260, 1972.
4. Otter R, Gerrits WBJ, Sandt MM, Hermans J and Willemze R: Primary extranodal and nodal non-Hodgkin's lymphoma: a survey of a population-based registry. Eur J Cancer Clin Oncol 25: 1203-1210, 1989.
5. D'Amore F, Christensen BE, Brincker H, Pedersen NT, Thorling K, Hastrup J, Pedersen M, Jensen MK, Johansen P and Andersen E: Clinico-pathological features and prognostic factors in extranodal non-Hodgkin's lymphomas. Eur J Cancer 27: 1201-1208, 1991.
6. Bennett MH, Farrer-Brown G, Henry K and Jelliffe AM: Classification of non-Hodgkin's lymphomas. Lancet II: 405-406, 1974.
7. Carbone PP, Kaplan HS, Musshoff K, Smithers DW and Tubiana M: Report of the committee on Hodgkin's disease staging classification. Cancer Res 31: 1860-1861, 1971.
8. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329: 987-994, 1993.
9. Sutcliffe SB and Gospodarowicz MK: Clinical features and management of localised extranodal lymphomas. In: Haematological Oncology. Keating A, Armitage J, Burnet A, et al (eds). Vol. 2. Cambridge Univesity Press, Cambridge, pp 189-223, 1992.
10. Tondini C, Zanini M, Lombardi F, Bcngala C, Rocca A, Giardini R, Buzzoni R, Valagussa P and Bonadonna G: Combined modality treatment with primary CHOP chemotherapy followed by Iocoregional irradiation in stage I and II histologically aggressive non-Hodgkin's lymphomas. J Clin Oncol 11: 720-725, 1993.
11. Gospodarowicz MK, Robinson MH and Sutcliffe SB: Non-Hodgkin's Iymphoma: localised disease. In: Malignant Lymphoma. Hancock BW, Selby P, Armitage J and McLcnnon K (eds). London (In press).
12. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, de Wolf-Peeters C, Falini B and Gatter KC: From the International Lymphoma Study Group. Blood 84: 1361-1392, 1994.
13. Cavalli F: Extranodal lymphomas. In: The Non-Hodgkin's Lymphomas. Magrath I (ed). 2nd edition. Arnold, London, pp1007-1027.
14. Hancock BW, Aitken M, Radstone C and Vaughan Hudson G: Why don't cancer patients get entered into clinical trials? Experience of the Sheffield Lymphoma Group's collaboration in British National Lymphoma Investigation studies. BMJ 314: 36-37, 1997.